Contributing Authors: Carrie Wright, David A. Ross, and Daniel R. Weinberger
Author Affiliation: From the Lieber Institute for Brain Development (CW, DRW), Department of Psychiatry and Behavioral Sciences (DRW), Department of Neurology (DRW), The Solomon H. Snyder Department of Neuroscience (DRW), and the McKusick-Nathans Institute of Genetic Medicine (DRW), Johns Hopkins University School of Medicine, Baltimore, Maryland; and the Department of Psychiatry (DAR), Yale University, New Haven, Connecticut. CW was formally a postdoctoral fellow in the AstraZeneca postdoctoral program during the writing of this commentary. Clinical Commentaries are produced in collaboration with the National Neuroscience Curriculum Initiative (NNCI). David A. Ross, in his dual roles as co-chair of the NNCI and as Education Editor of Biological Psychiatry, manages the development of these commentaries but plays no role in the decision to publish each commentary. The NNCI is supported by the National Institutes of Health Grant Nos. R25 MH08646607S1 and R44 MH115546-01.
This work was supported by a Brain and Behavior Research Foundation Young Investigator Award, the Burroughs-Wellcome Fund Career Award for Medical Scientists, the Yale Department of Psychiatry, and the Yale School of Medicine (to AP), National Institute of Mental Health Grant Nos. K23 MH115252-01A1 (to ARP) and R01MH1128875 and R01MH067073-09 (to PRC), an International Mental Health Review Order/Janssen Rising Star Translational Research Award, Clinical and Translational Science Awards Grant No. UL1 TR000142 from the National Center for Research Resources and the National Center for Advancing Translational Science, components of the National Institutes of Health, the National Institutes of Health Roadmap for Medical Research, Clinical Neurosciences Division, U.S. Department of Veterans Affairs, and the National Center for Post-Traumatic Stress Disorders, Veterans Affairs Connecticut Healthcare System (to PRC). The contents of this work are solely the responsibility of the authors and do not necessarily represent the official view of National Institutes of Health or the Connecticut Mental Health Center/Division of Mental Health and Addiction Services.
The authors report no biomedical financial interests or potential conflicts of interest.
1 Response
Leave a Reply
You must be logged in to post a comment.
Very interesting new topic! I had residents read and discuss the Biological Psychiatry Clinical Commentary called “Using Neuroscience to Make Sense of Psychopathy”, then they practiced formulating the case of Charles Whitman (using the info from Wikipedia), then we followed that with reading and discussing this BPCC on microRNA. They enjoyed it.